Macro Dragon: +15K Cases In China, Put a Fork in Biden - perhaps even Warren? Macro Dragon: +15K Cases In China, Put a Fork in Biden - perhaps even Warren? Macro Dragon: +15K Cases In China, Put a Fork in Biden - perhaps even Warren?

Macro Dragon: +15K Cases In China, Put a Fork in Biden - perhaps even Warren?

Macro 2 minutes to read
Kay Van-Petersen

Global Macro Strategist

Summary:  As the Asia Thu morning start, we got news that have taken Equity Futures from green to red, with S&P futures currently down -0.30% on the news that we have potentially c. +15,000 new cases found in the province of Hubei - due to revised testing methods. This would take the confirmed cases to 60,000, which is on track to get to the 7 figures that we have been extrapolating on, since the 2019-nCoV now formally called Covid-19 kicked off. We also check in on US politics - put a fork in Biden! And see some central bankers comment on the virus as well as China stimulus.

(These are solely the views & opinions of KVP, & do not constitute any trade or investment recommendations. By the time you synthesize this, things may have changed.)



Macro Dragon:+15K New Virus Cases + Put a fork in Biden & perhaps also Warren?


US Elections Checks in & Other Thoughts…

  • Bernie took NH, with Buttigieg close on his heels… As has been flagged to KVP (& believe we mentioned that IO & NH are very white states), Buttigieg base seems to be progressive, wealthy white folks, with actually very little traction on millennials despite at 38 him being much younger than the rest of the field. Millennials love ‘The Bern’. Klobuchar likely also took some wind out of Buttigieg sales (lucky for Sanders), yet she came in above Warren.
  • Unless Bernie stumbles any time soon (Unlikely), Warren is likely done – some massive time decay on that vehicle. Buttigieg & Klobuchar are likely going to struggle again the non-white base, as well as the less wealthy… stay tuned.
  • Meanwhile markets don’t really seem to care on any risk of a Sanders nomination – whether that’s because its priced correctly (i.e. he has not chance), its too early in the cycle & is not dominating enough, Trump has it in the bag, etc… too early to tell.


Covid-19 Update Thu Asia Mrn 12 Feb & Thoughts…


Quick update & thoughts on the Virus since the Yest’s check in:

  • As of this Wed 13 Asia morning, the China figures we are getting are at c. 45,200 confirmed cases, +1120 deaths & +5,150 recovered. So suggesting a considerable slowdown in confirmed cases in China & big uptick in those recovering.   
  • However a breaking news headline suggest that we may need to add up to +15,000 new cases stemming from the province of Hubei (60m people), given new methods used to test & screen for the coronavirus
  • This has sent S&P futures from positive territory to c. -0.40% to -0.50% lower this early morning Asia. If this is true, that would take confirmed cases in China to +60,000. As the Macro Dragon have conservatively stipulated before, given the population & seasonal dynamics of China – we likely get into the 6 figures before the Covid-19 is fully contained. And again 60,000 in a province of 60m (funnily enough the number of Americans infected with the H1N1 swine flu virus that broke out in the US in 2009), is only 0.10%.
  • One last point, a lot of countries are starting to put restrictions on travel to places like Singapore – this again is the paradox of circles of silence (just because the data is not there, does not mean there is no data). What people should be instead thinking is, if Singapore with its incredible experience, resources & organization honed through SARs has found these 50 cases, what is the “REAL” case count in other countries? i.e. Indonesia with 230m, Thailand with 70m, all whom also do a tremendous amount of business & travel with China.
  • Obviously an element of this is political – you have to be seen to be doing something, regardless of whether that action is actually fruitful or futile.
  • BoC’s Poloz is saying to early to really process the effects of the virus. And RBA’s Lowe point out that China has indicated that they will stimulate which should be good for the Australian economy. You have to wonder whether we could see an RBA similar to RBNZ o/n which did not cut rates as per expectations, yet seemed to signal that there would be no cuts in 2020 – sending the kiwi higher against crosses, there could be quite a bit of juice left here over the year (i.e. get to the other side of CH data gaining).

Outside of China the countries with confirmed cases over 10 are:

  • Japan 202 (174 from the cruise ship)
  • Hong Kong 50 (+1)
  • Singapore 50 (+3)
  • Thailand 33 (+1)
  • South Korea 28
  • Taiwan 18
  • Malaysia 18
  • Germany 16
  • Australia 15
  • Vietnam 15
  • United States 13 (+1)
  • France 11
  • Macau 10



      Have a fantastic, gratitude & abundant filled close to the wk everyone, stay healthy as well as keep your mind open to profitable & abundant opportunities. Life happens for us, not to us.  




      Some Anchor Pieces from #SaxoStrats:

      Quarterly Outlook 2024 Q3

      Sandcastle economics

      01 / 05

      • Macro: Sandcastle economics

        Invest wisely in Q3 2024: Discover SaxoStrats' insights on navigating a stable yet fragile global economy.

        Read article
      • Bonds: What to do until inflation stabilises

        Discover strategies for managing bonds as US and European yields remain rangebound due to uncertain inflation and evolving monetary policies.

        Read article
      • Equities: Are we blowing bubbles again

        Explore key trends and opportunities in European equities and electrification theme as market dynamics echo 2021's rally.

        Read article
      • FX: Risk-on currencies to surge against havens

        Explore the outlook for USD, AUD, NZD, and EM carry trades as risk-on currencies are set to outperform in Q3 2024.

        Read article
      • Commodities: Energy and grains in focus as metals pause

        Energy and grains to shine as metals pause. Discover key trends and market drivers for commodities in Q3 2024.

        Read article


      The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

      Please read our disclaimers:
      - Notification on Non-Independent Investment Research (
      - Full disclaimer (

      40 Bank Street, 26th floor
      E14 5DA
      United Kingdom

      Contact Saxo

      Select region

      United Kingdom
      United Kingdom

      Trade Responsibly
      All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
      Additional Key Information Documents are available in our trading platform.

      Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

      This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

      It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

      Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

      ©   since 1992